Interferon-alfacon-1 shows efficacy in patients with chronic hepatitis C who have not responded to, or relapsed after, prior therapy with IFN- -2b plus ribavirin

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1256, 2000-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Arguedas M.  

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 477-479

Adis International

Access to resources Recommend Favorite

Interferon (IFN)- -2b is effective in patients with mild chronic hepatitis C

By  

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Which is the Most Cost-Effective Combination Therapy Strategy Using Interferon -2b plus Ribavirin for Naïve Patients with Chronic Hepatitis C?

By Buti M.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors' Reply

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 478-479

Adis International

Access to resources Recommend Favorite